Neuropsychiatric symptom clusters across the cognitive impairment spectrum in advanced age: a data-driven analysis integrating AD biomarker and clinical profiling
Data-driven clustering was used to identify NPS clusters in 300 individuals using the 12 domains of Neuropsychiatric Inventory, consistent with a parallel-pathway hypothesis: measured AD pathology and NPS clusters showed largely independent associations with cognition, with only partial overlap in their associations with functional status.
Abstract
Neuropsychiatric symptoms (NPS) are among the most common manifestations of cognitive impairment, yet their heterogeneity complicates understanding of how they relate to Alzheimer’s disease (AD) pathology. While individual NPS have been linked to AD biomarker burden, the interplay between co-occurring neuropsychiatric profiles and AD biomarkers in shaping cognitive and functional outcomes remains insufficiently understood. This study used data-driven clustering to identify NPS clusters in 300 individuals (156 mild cognitive impairment, 112 AD dementia, 32 non-AD dementia) using the 12 domains of Neuropsychiatric Inventory. K-means clustering identified three clusters: Minimal/No NPS (55.7%), Apathy-Behavioral Dysregulation (17.7%), and Depression-Anxiety/Affective (26.7%). Clusters differed significantly in age, sex, education, cognitive status, and diagnostic composition (all
p
< .05). The Apathy-Behavioral cluster showed advanced cognitive impairment and AD/non-AD dementia predominance, whereas the Depression-Anxiety cluster showed preserved cognition, female predominance, and highest vascular risk factor prevalence. Measured AD pathology (plasma pTau217, CSF amyloid and tau) did not differ across clusters, whereas APOE ε4 carriership was higher in the two symptomatic clusters (both 44.4% vs. 26.0%;
p
= .032), an association that did not persist after multivariable adjustment. Hierarchical regression revealed five of eight biomarker-outcome associations were largely independent of NPS clusters (change < 10%), with exceptions involving functional outcome: pTau217 (11.4%), tau (17.7%), and APOE ε4 (29.6%). Findings are consistent with a parallel-pathway hypothesis: measured AD pathology and NPS clusters showed largely independent associations with cognition, with only partial overlap in their associations with functional status.
Neuropsychiatric symptoms (NPS) are prevalent in older adults and are associated with cognitive decline. This study investigated the association between hyperarousal NPS (HNPS) and cognitive progression, focusing on the mediating role of functional impairment and its link to Alzheimer’s disease (AD) pathology....
Xue-Zhi Shi, Gui-Lin Chen, Fang-Min Lu et al.· Frontiers in Aging Neuroscie...· 0 citations
Objective: Neuropsychiatric symptoms are common in neurodegenerative syndromes, but assessment relies upon informant report, which may be susceptible to bias. This study examined whether Neuropsychiatric Inventory Questionnaire symptom severity (NPI-Q-SS) varies as a function of informant characteristics in Alzheimer...
A. Rodriguez, K. Dhima, Oscar R. Kronenberger et al.· Archives of Clinical Neurops...· 0 citations
These findings support the distinction between motivational and mood syndromes and highlight apathy and depression as clinically meaningful contributors to functional decline in parkinsonian disorders.
Andrea Collins, Jordan Kozuki, Lily Wilkin et al.· Archives of Clinical Neurops...· 0 citations
Different NPSs appear to be differentially associated with caregiver outcomes, despite the lack of caregiver-level covariates, supporting the need for multidimensional and caregiver-centered approaches in dementia care.
M. C. Moretti, I. Bonfitto, L. Nieddu et al.· Journal of Dementia and Alzh...· 0 citations
Neuropsychiatric symptoms (NPSs) are highly prevalent in Alzheimer’s disease (AD) and may accelerate cognitive decline, but the molecular mechanisms linking NPSs to AD pathology remain unclear.
In this cross–sectional study, we analyzed 713 Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants wi...
Findings suggest MCI diagnosis may not substantially influence concordance of mood reporting in patients, though patient self-report remains clinically informative in MCI, though agreement with caregiver ratings is limited.
Danny Quan, Lauren Bennett, Michael LaSorsa· Archives of Clinical Neurops...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.